Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
CRIS > SEC Filings for CRIS > Form 8-K on 15-Aug-2013All Recent SEC Filings

Show all filings for CURIS INC

Form 8-K for CURIS INC


Change in Directors or Principal Officers, Other Events, Financial Statements and Exhib

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On August 12, 2013, Maurizio Voi, M.D., the Chief Medical and Chief Development Officer and Executive Vice President of Curis, Inc. (the "Company"), departed the Company to pursue other opportunities.

Item 8.01. Other Events

On August 13, 2013, the board of directors of the Company appointed Jaye Viner, M.D. as its Chief Medical Officer and Executive Vice President.

Dr. Viner, Age 57, served as a Medical Director at Millennium: The Takeda Oncology Company, a biotechnology company, from April 2012 until August 2013, and as an Associate Director, Clinical Development - Oncology at MedImmune, LLC. (AstraZeneca) from April 2009 until April 2012. From 1995 until March 2009, Dr. Viner held senior leadership positions at the National Cancer Institute and the National Institutes of Health, including Deputy and Acting Director of the Office of Centers, Training and Resources, and Chief of the Gastrointestinal and Other Cancers Research Group in the Division of Cancer Prevention.

On August 13, 2013, the Company issued a press release announcing the appointment of Dr. Viner, M.D. as Chief Medical Officer and Executive Vice President and the departure of Dr. Voi from the same position. The full text of the press release issued in connection with this announcement is attached hereto as Exhibit 99.1 and is incorporated into this Item 8.01 by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

See Exhibit Index attached hereto.

  Add CRIS to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for CRIS - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.